108 related articles for article (PubMed ID: 35841956)
1. Low molecular weight fucoidan alleviates cerebrovascular damage by promoting angiogenesis in type 2 diabetes mice.
Li Z; Wu N; Wang J; Yue Y; Geng L; Zhang Q
Int J Biol Macromol; 2022 Sep; 217():345-355. PubMed ID: 35841956
[TBL] [Abstract][Full Text] [Related]
2. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight fucoidan restores diabetic endothelial glycocalyx by targeting neuraminidase2: A new therapy target in glycocalyx shedding.
Li Z; Wu N; Wang J; Yue Y; Geng L; Zhang Q
Br J Pharmacol; 2024 May; 181(9):1404-1420. PubMed ID: 37994102
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
Zheng Y; Liu T; Wang Z; Xu Y; Zhang Q; Luo D
Int J Biol Macromol; 2018 Jun; 112():929-936. PubMed ID: 29447962
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
6. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.
Chen MC; Hsu WL; Hwang PA; Chou TC
Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287
[TBL] [Abstract][Full Text] [Related]
7. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.
Haddad O; Guyot E; Marinval N; Chevalier F; Maillard L; Gadi L; Laguillier-Morizot C; Oudar O; Sutton A; Charnaux N; Hlawaty H
Mar Drugs; 2015 Oct; 13(11):6588-608. PubMed ID: 26516869
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum.
Marinval N; Saboural P; Haddad O; Maire M; Bassand K; Geinguenaud F; Djaker N; Ben Akrout K; Lamy de la Chapelle M; Robert R; Oudar O; Guyot E; Laguillier-Morizot C; Sutton A; Chauvierre C; Chaubet F; Charnaux N; Hlawaty H
Mar Drugs; 2016 Oct; 14(10):. PubMed ID: 27763505
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight fucoidan ameliorates hindlimb ischemic injury in type 2 diabetic rats.
Wang Z; Liu T; Chen X; You H; Zhang Q; Xue J; Zheng Y; Luo D
J Ethnopharmacol; 2018 Jan; 210():434-442. PubMed ID: 28917976
[TBL] [Abstract][Full Text] [Related]
11. Low-Molecular-Weight Fucoidan Induces Endothelial Cell Migration via the PI3K/AKT Pathway and Modulates the Transcription of Genes Involved in Angiogenesis.
Bouvard C; Galy-Fauroux I; Grelac F; Carpentier W; Lokajczyk A; Gandrille S; Colliec-Jouault S; Fischer AM; Helley D
Mar Drugs; 2015 Dec; 13(12):7446-62. PubMed ID: 26694425
[TBL] [Abstract][Full Text] [Related]
12. Low-Molecular-Weight Fucoidan Attenuates Mitochondrial Dysfunction and Improves Neurological Outcome After Traumatic Brain Injury in Aged Mice: Involvement of Sirt3.
Wang T; Zhu M; He ZZ
Cell Mol Neurobiol; 2016 Nov; 36(8):1257-1268. PubMed ID: 26743530
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.
Liang Z; Zheng Y; Wang J; Zhang Q; Ren S; Liu T; Wang Z; Luo D
J Ethnopharmacol; 2016 Sep; 191():341-349. PubMed ID: 27346541
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
Lake AC; Vassy R; Di Benedetto M; Lavigne D; Le Visage C; Perret GY; Letourneur D
J Biol Chem; 2006 Dec; 281(49):37844-52. PubMed ID: 17028197
[TBL] [Abstract][Full Text] [Related]
15. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H
Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of low molecular weight fucoidan from Saccharina japonica on atherosclerosis in apoE-knockout mice.
Xu Y; Xu J; Ge K; Tian Q; Zhao P; Guo Y
Int J Biol Macromol; 2018 Oct; 118(Pt A):365-374. PubMed ID: 29906534
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucoidan alleviates diabetic nephropathy by binding fibronectin and inhibiting ECM-receptor interaction in human renal mesangial cells.
Wang J; Zhang Q; Li S; Chen Z; Tan J; Yao J; Duan D
Int J Biol Macromol; 2020 May; 150():304-314. PubMed ID: 32057847
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine.
Liu L; Xing R; Xue J; Fan J; Zou J; Song X; Jia R; Zou Y; Li L; Zhou X; Lv C; Wan H; Zhao X; Yin Z
Int J Pharm; 2023 Jul; 642():123102. PubMed ID: 37277087
[TBL] [Abstract][Full Text] [Related]
20. Low Molecular Weight Fucoidan Inhibits Pulmonary Fibrosis In Vivo and In Vitro via Antioxidant Activity.
Dong H; Xue T; Liu Y; He S; Yi Y; Zhang B; Xin J; Wang Z; Li X
Oxid Med Cell Longev; 2022; 2022():7038834. PubMed ID: 35281460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
